Medicure Incorporated (TSXV: MPH, OTC: MCUJD.PK), a pharmaceutical company, announced yesterday that it has named Dr Neil Owens as its new President and Chief Operating Officer, effective 1 July 2019.
Owens will be responsible for implementing the company's strategic plans, and managing day-to-day operations, including the advancement and management of new and existing pharmaceutical products.
Owens has worked at Medicure since 2014, serving most recently as Director, Scientific Affairs. Owens holds a Bachelor of Science and a PhD in Chemistry from the University of Manitoba and has Post Doctoral experience with the IECB.
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers
INOVIO announces inducement grant to new employee
AbbVie's Allergan Aesthetics announces Natrelle supplier agreement with Vizient
Karyopharm Therapeutics awards inducement grants to new employees
POLYTECH Health & Aesthetics announces Poland expansion
Santhera Pharmaceuticals signs Gulf region distribution agreement with Uniphar